[1]
Kumar B, Sharma D. Recent patent advances for neurodegenerative disorders and its treatment. Recent Pat Drug Deliv Formul 2017; 11(3): 158-72.
[5]
Chiavacci E, Terzibasi Tozzini E, Fairuz Azman K, Zakaria R. Recent advances on the role of brain-derived neurotrophic factor (BDNF). Neurodegener Dis 2022; 33(12): 6827.
[8]
Gudasheva TA. Design and synthesis of dipeptide mimetics of brain-derived neurotrophic factor. Bioorg Khim 2012; 38(3): 280-90.
[9]
Robinson RC, Choe S, Radziejewski C, et al. The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site. Protein Sci 1999; 8(12): 2589-97.
[10]
Du X, Hill RA. 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders. Neurochem Int 2015; 89: 170-80.
[11]
Gudasheva TA, Logvinov IO. Dipeptide mimetics of different NGF and BDNF loops activate PLC-γ1. Dokl Biochem Biophys 2020; 494(1): 244-7.
[12]
Zainullina LF. Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression. Sci Rep 2021; 11(1): 7781.
[15]
Wong AW, Giuffrida L, Wood R, et al. TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination. Mol Cell Neurosci 2014; 63: 132-40.
[17]
Simmons DA, Belichenko NP, Yang T, et al. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington’s disease. J Neurosci 2013; 33(48): 18712-2.
[20]
Yu G, Wang W. Protective effects of LM22A-4 on injured spinal cord nerves. Int J Clin Exp Pathol 2015; 8(6): 6526-32.
[22]
Chakravarthy B, Gaudet C, Ménard M, et al. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis 2010; 19(3): 915-25.
[24]
Simmons DA, Knowles JK, Belichenko NP, et al. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer’s disease mouse models with mid- to late-stage disease progression. PLoS One 2014; 9(8): e102136.
[25]
Krishnan N, Krishnan K, Connors CR, et al. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest 2015; 125(8): 3163-77.
[27]
Zhang Z, Liu X, Schroeder JP, et al. 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 2014; 39(3): 638-50.
[28]
Aytan N, Choi JK, Carreras I, et al. Protective effects of 7,8-Dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer’s disease. Eur J Pharmacol 2018; 828: 9-17.
[29]
Castello NA, Nguyen MH, Tran JD, Cheng D, Green KN, LaFerla FM. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One 2014; 9(3): e91453.
[30]
Luo D, Shi Y, Wang J, et al. 7,8-Dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents. Neurosci Lett 2016; 620: 43-9.
[31]
Sconce MD, Churchill MJ, Moore C, Meshul CK. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson’s disease. Neuroscience 2015; 290: 454-71.
[32]
Nie S, Ma K, Sun M, et al. 7,8-Dihydroxyflavone protects nigrostriatal dopaminergic neurons from rotenone-induced neurotoxicity in rodents. Parkinsons Dis 2019; 2019: 9193534.
[33]
Barriga GGD, Giralt A, Anglada-Huguet M, et al. 7,8-Dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington’s disease mouse model through specific activation of the PLCγ1 pathway. Hum Mol Genet 2017; 26(16): 3144-60.
[35]
Korkmaz OT, Aytan N, Carreras I, et al. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett 2014; 566: 286-91.
[36]
Paul R, Nath J, Paul S, et al. Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorder. Neurochem Int 2021; 148: 105068.
[37]
Brinkley G, Nam H, Shim E, et al. Restoration of motor learning in a mouse model of Rett syndrome following long-term treatment with a novel small-molecule activator of TrkB. Dis Model Mech 2020; 13(11): dmm044685.
[39]
Liu X, Chan CB, Jang SW, et al. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem 2010; 53(23): 8274-6.
